Results 141 to 150 of about 1,124,319 (216)

Epidermal Growth Factor Receptor (EGFR)-Targeting Peptides and Their Applications in Tumor Imaging Probe Construction: Current Advances and Future Perspectives. [PDF]

Biology (Basel)
Huang L, Dong Y, Li J, Yang X, Li X, Wu J, Huang J, Zhang Q, Wan Z, Hu S, Feng R, Li G, Huang X, Zhang P.   +13 more
europepmc   +1 more source

Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti-Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer. [PDF]

Clin Cancer Res
Petricoin EF, Wolf DM, Yau C, Wulfkuhle JD, Van't Veer L, Gallagher RI, Esserman LJ, Hirst GL, Brown-Swigart L, Yee D, I-SPY2 Trial Consortium.   +10 more
europepmc   +1 more source

Deciphering prognostic markers in gastric signet ring cell carcinoma: Human epidermal growth factor receptor 2 and other key factors. [PDF]

World J Clin Oncol
Ebrahim NAA, Othman MO, Tahoun NS, Salama RA, Arafat A, Amin NH.   +5 more
europepmc   +1 more source

Vacuole protein sorting 18 (Vps18) suppresses epithelial growth factor receptor (EGFR) expression and lung tumorigenesis. [PDF]

J Biol Chem
Dai W, Zhang S, Yan S, Zhang H, Zou S, Yu T, Tao W, Ke H, Du X.   +8 more
europepmc   +1 more source

EGFR^AP: a predictive machine learning model for assessing small molecule activity against the epidermal growth factor receptor. [PDF]

RSC Med Chem
Gupta A, Thind AS, Purohit R.
europepmc   +1 more source

Molecular docking analysis of pyrrole derivatives with the human epidermal growth factor receptor 2: Combating breast cancer. [PDF]

Bioinformation
Ilango S, Sathish Kumar BY, K G.
europepmc   +1 more source

Structure-based identification of potent fibroblast growth factor receptor 4 (FGFR4) inhibitors as potential therapeutics for hepatocellular carcinoma. [PDF]

PeerJ
Fan L, Xie H, Wang W, Peng G, Fu Z, Ye Q.   +5 more
europepmc   +1 more source